How Pagaya’s US$800 Million AAA ABS Deal And New Funding Partners At Pagaya Technologies (PGY) Has Changed Its Investment Story

Pagaya Technologies +0.60%

Pagaya Technologies

PGY

11.77

+0.60%

  • Pagaya Technologies recently closed an US$800 million AAA-rated personal loan asset-backed securities transaction, its 85th ABS deal and largest securitization since November 2024, while also reporting Q3 updates that included new lending partners, a record onboarding pipeline, and enhanced liquidity from corporate debt issuance and funding agreements.
  • Together with KBRA’s preliminary ratings on a new unsecured consumer loan ABS transaction, these developments underscore Pagaya’s scale in structured finance and the breadth of institutional demand for its AI-enabled consumer credit assets.
  • We’ll now examine how the successful US$800 million AAA-rated securitization shapes Pagaya’s investment narrative and perceived business model resilience.

The future of work is here. Discover the 28 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

What Is Pagaya Technologies' Investment Narrative?

To own Pagaya today, you have to believe its AI-driven B2B2C lending network can keep attracting funding partners and institutional ABS buyers while scaling profitably from a still-small earnings base. The US$800 million AAA personal loan deal and KBRA’s new unsecured consumer loan ABS ratings help the short term story by reinforcing access to capital markets and validating demand for its credit models, especially after the recent share pullback and earlier concerns around funding costs. Combined with stronger liquidity from corporate debt and a growing partner roster, the near term catalysts look more about sustained deal flow, Q4 2025 delivery versus raised guidance, and any updates at the February earnings release than about this single transaction. Key risks, though, now skew even more toward funding conditions, credit performance, and ABS market appetite.

However, one key funding-related risk here is easy to underestimate and important for investors to understand. Despite retreating, Pagaya Technologies' shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

PGY 1-Year Stock Price Chart
PGY 1-Year Stock Price Chart
Eight fair value views from the Simply Wall St Community span US$27 to over US$309, reflecting highly varied expectations. Set against Pagaya’s reliance on securitization markets, this spread shows how differently investors are weighing funding and credit risks.

Explore 8 other fair value estimates on Pagaya Technologies - why the stock might be a potential multi-bagger!

Build Your Own Pagaya Technologies Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Pagaya Technologies research is our analysis highlighting 3 key rewards that could impact your investment decision.
  • Our free Pagaya Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Pagaya Technologies' overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

  • AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • Find 53 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.